Skip to main content
. 2020 May 28;12(6):491. doi: 10.3390/pharmaceutics12060491

Table 2.

Conditions tested in skin permeation and retention experiments (the number of replicates is indicated in parentheses).

2% Ointment 2% ACN Solution [17]
Intact Skin Damaged Skin Intact Skin
Contact Time (h) Epidermis/Dermis Retention Stratum Corneum Distribution Epidermis/Dermis Retention Epidermis/Dermis Retention
4 X (4) X (4) X (4)
8 X (8)
16 X (4) X (4) X (6)
24 X (7)